SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0001193125-20-293174
Filing Date
2020-11-13
Accepted
2020-11-13 17:04:32
Documents
18

Document Format Files

Seq Description Document Type Size
1 PRER14A d36630dprer14a.htm PRER14A 1133392
2 GRAPHIC g366301n.jpg GRAPHIC 8505
3 GRAPHIC g366302.jpg GRAPHIC 7653
4 GRAPHIC g36630g01v55.jpg GRAPHIC 34767
5 GRAPHIC g36630g04x31.jpg GRAPHIC 61517
6 GRAPHIC g36630g10u26.jpg GRAPHIC 115943
7 GRAPHIC g36630g12k00.jpg GRAPHIC 45641
8 GRAPHIC g36630g15k32.jpg GRAPHIC 50222
9 GRAPHIC g36630g16m01.jpg GRAPHIC 32404
10 GRAPHIC g36630g22y12.jpg GRAPHIC 102646
11 GRAPHIC g36630g48y58.jpg GRAPHIC 26000
12 GRAPHIC g36630g52t54.jpg GRAPHIC 18454
13 GRAPHIC g36630g78t73.jpg GRAPHIC 52153
14 GRAPHIC g36630g82m04.jpg GRAPHIC 60167
15 GRAPHIC g36630g86s35.jpg GRAPHIC 51482
16 GRAPHIC g36630img03.jpg GRAPHIC 1674
17 GRAPHIC g36630img04.jpg GRAPHIC 1787
18 GRAPHIC g36630img05.jpg GRAPHIC 1838
  Complete submission text file 0001193125-20-293174.txt   2029483
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 001-36620 | Film No.: 201312413
SIC: 2834 Pharmaceutical Preparations